442 related articles for article (PubMed ID: 19768207)
1. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
Chen Y; Zhang R; Song Y; He J; Sun J; Bai J; An Z; Dong L; Zhan Q; Abliz Z
Analyst; 2009 Oct; 134(10):2003-11. PubMed ID: 19768207
[TBL] [Abstract][Full Text] [Related]
2. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.
Woo HM; Kim KM; Choi MH; Jung BH; Lee J; Kong G; Nam SJ; Kim S; Bai SW; Chung BC
Clin Chim Acta; 2009 Feb; 400(1-2):63-9. PubMed ID: 19010317
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
5. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
6. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification.
Nam H; Chung BC; Kim Y; Lee K; Lee D
Bioinformatics; 2009 Dec; 25(23):3151-7. PubMed ID: 19783829
[TBL] [Abstract][Full Text] [Related]
7. Time-course changes in potential biomarkers detected using a metabonomic approach in Walker 256 tumor-bearing rats.
Shen G; Chen Y; Sun J; Zhang R; Zhang Y; He J; Tian Y; Song Y; Chen X; Abliz Z
J Proteome Res; 2011 Apr; 10(4):1953-61. PubMed ID: 21275377
[TBL] [Abstract][Full Text] [Related]
8. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
9. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
[TBL] [Abstract][Full Text] [Related]
10. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
[TBL] [Abstract][Full Text] [Related]
11. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
[TBL] [Abstract][Full Text] [Related]
12. Assessment of data pre-processing methods for LC-MS/MS-based metabolomics of uterine cervix cancer.
Chen Y; Xu J; Zhang R; Shen G; Song Y; Sun J; He J; Zhan Q; Abliz Z
Analyst; 2013 May; 138(9):2669-77. PubMed ID: 23486772
[TBL] [Abstract][Full Text] [Related]
13. Urinary metabonomic study of lung cancer by a fully automatic hyphenated hydrophilic interaction/RPLC-MS system.
Yang Q; Shi X; Wang Y; Wang W; He H; Lu X; Xu G
J Sep Sci; 2010 Jun; 33(10):1495-503. PubMed ID: 20309903
[TBL] [Abstract][Full Text] [Related]
14. Integrated GC-MS and LC-MS plasma metabonomics analysis of ankylosing spondylitis.
Gao P; Lu C; Zhang F; Sang P; Yang D; Li X; Kong H; Yin P; Tian J; Lu X; Lu A; Xu G
Analyst; 2008 Sep; 133(9):1214-20. PubMed ID: 18709197
[TBL] [Abstract][Full Text] [Related]
15. Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.
Tian H; Bai J; An Z; Chen Y; Zhang R; He J; Bi X; Song Y; Abliz Z
Rapid Commun Mass Spectrom; 2013 Sep; 27(18):2071-80. PubMed ID: 23943328
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
[TBL] [Abstract][Full Text] [Related]
17. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
Zhu C; Liang QL; Hu P; Wang YM; Luo GA
Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
[TBL] [Abstract][Full Text] [Related]
18. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
[TBL] [Abstract][Full Text] [Related]
19. Urinary metabonomic study on colorectal cancer.
Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
[TBL] [Abstract][Full Text] [Related]
20. Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer.
Lin L; Yu Q; Yan X; Hang W; Zheng J; Xing J; Huang B
Analyst; 2010 Nov; 135(11):2970-8. PubMed ID: 20856980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
